Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2009, p. 1709-1711, Vol. 53, No. 4
0066-4804/09/$08.00+0 doi:10.1128/AAC.01014-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
,
Department of Veterinary Pathobiology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg C, Denmark
Received 29 July 2008/ Returned for modification 1 November 2008/ Accepted 25 January 2009
|
|
|---|
|
|
|---|
A statistical association between the prophylactic use of ceftiofur and the occurrence of cefotaxime-resistant E. coli in healthy pigs was recently demonstrated at two Danish pig farms, and most of the isolates were shown to be CTX-M-1 producers (11). In this study, we revisited the farms 1 year after the previous study to investigate the distribution, persistence, and transmission of blaCTX-M-1 between pigs, farm workers, and the farm environment. Fecal samples were randomly obtained from one sow-piglet pair or weaner in every fifth pen. Limited to one farm, composite manure samples were collected from pens containing slaughter pigs. Environmental surface swabs were collected from door handles, wash areas, and food carts. Rectal swabs were obtained from four consenting farm workers and one family member. All samples were cultured on MacConkey agar (Oxoid) plates containing cefotaxime (2 µg/ml). Air samples were obtained by exposing cefotaxime plates to air for 1 h. The identification of colonies with typical E. coli morphology was confirmed by the citrate, indole, methyl red, and Voges-Proskauer tests. The presence of blaCTX-M-1 was determined by PCR using CTX-M universal primers (9) and by DNA sequencing using CTX-M-1-specific primers (F primer, 5'-CCATGGTTAAAAAATCACTGCG-3', and R primer, 5'-GTRAARTARGTSACCAGAAYSAGCGG-3'). The 803-bp fragment (approximately 92% of the entire gene) displayed 100% nucleotide and predicted amino acid identity to blaCTX-M-1.
E. coli producing CTX-M-1 was detected at high frequencies in animal, human, and environmental samples from both farms (Table 1). Most pigs (56/70) harbored CTX-M-1-positive E. coli, including 20 of the 30 sow-piglet pairs tested. CTX-M-1-producers were also isolated from three of the four samples from the farm workers and from the manure and air samples but not from the surface swabs or from the sample from the family member, who did not have daily exposure to the pigs. Four E. coli phylogenetic groups (A, B1, B2, and D) were detected by multiplex PCR (60%, 22%, 6%, and 12%, respectively) (4) (Table 1). XbaI pulsed-field gel electrophoresis (PFGE) (3) was used to investigate the genetic diversity among the 55 typeable CTX-M-1-producing isolates (see Fig. S1 in the supplemental material). Nineteen isolates from the previous study (11) were included to assess the possible persistence of CTX-M-1-producing E. coli clones. PFGE cluster analysis (unweighted-pair group method using average linkages, Dice similarity coefficient, optimization, and position tolerance of 2%) was done by Gelcompar II (Applied Maths, Belgium), resulting in 15 PFGE types displaying less than 80% similarity and 63 subtypes showing minor band differences within PFGE types. Indistinguishable PFGE patterns were observed only in isolates from farm 2 on four occasions, including two piglet isolates from 2006 and one human isolate from 2007.
|
View this table: [in a new window] |
TABLE 1. Occurrence and diversity of blaCTX-M-1-positive E. coli
|
15 mm) and spectinomycin (R
10 mm; S/I
12 mm) was defined based on cutoff values determined by the distribution of inhibition zone diameters. Such values were in agreement with the clinical breakpoints for animal respiratory pathogens (6). Most (80%) isolates were resistant to two or more non-β-lactam antimicrobial classes. The human isolates showed variable resistance profiles, but all were resistant to at least four antimicrobial classes, including aminoglycosides, phenicols, tetracyclines, and sulfamethoxazole-trimethoprim. Ten strains from each farm displaying diverse PFGE subtypes or strain origins (pig, human, or environmental) and three strains from 2006 (20) (Table 2) were selected for plasmid characterization. Plasmids mediating cefotaxime resistance were transformed into electrocompetent Genehog E. coli (Invitrogen) using a Bio-Rad gene pulser and analyzed by replicon PCR (1) and restriction fragment length polymorphism (RFLP) using HincII and EcoRV. All plasmids belonged to IncN, and most (19/23) of them were either indistinguishable or closely related (RFLP type A) (Table 2). Four variants of plasmid RFLP type A were found in E. coli isolates from farm 1 (A1 to A3) and farm 2 (A4). Such variants were characterized by equal size (approximately 45 kb), identical EcoRV patterns, and up to two or three band differences following digestion with HincII (data not shown). The remaining four transformants contained IncN plasmids with different RFLP patterns (B to E). On farm 2, the plasmid detected in all the farm workers, the air sample, the manure, and most of the pigs was identical to that identified in the isolate from 2006 (RFLP pattern A4) and related to those found on farm 1 in 2006 (RFLP pattern A3) and 2007 (RFLP patterns A1 and A2). The cotransfer of resistance to non-β-lactam antimicrobials was only observed for three plasmids, and the cotransferred resistance genes were identified by PCR (8, 12, 13, 15) (Table 2). |
View this table: [in a new window] |
TABLE 2. Characterization of IncN plasmids harboring blaCTX-M-1 by RFLP analysis and replicon typing
|
The association between blaCTX-M-1 and IncN plasmids has previously been observed among porcine clinical E. coli isolates in Denmark (H. Hasman, unpublished data) and among human clinical isolates in Spain (16) and Italy (14). Less frequently, CTX-M-1 has been associated with other incompatibility groups, such as IncI1 in poultry in France (7) and IncL/M in human patients in Spain (16). The small band differences observed among the three most prevalent plasmids at farm 1 (RFLP patterns A1 to A3) and farm 2 (RFLP pattern A4) indicate that such plasmid variants may have originated from a common ancestor. The dissemination of this plasmid lineage in Danish pig farming could have been enhanced by the use of veterinary cephalosporins, as suggested by the fact that blaCTX-M-1 was the only detectable resistance gene. As indicated by the results of the previous cohort study (11), the high prevalences of CTX-M-1-producing E. coli observed among healthy pigs and farm workers in this study are likely to reflect the continuous selective pressure exerted through the prophylactic use of ceftiofur. The effects of veterinary cephalosporins on the selection of CTX-M-1-producing E. coli in the intestinal tracts of pigs have recently been illustrated under experimental conditions (2).
The spread of IncN plasmids carrying blaCTX-M-1 in pig farming may have significant implications for both human and animal health. Beside the zoonotic risk of transmission, there is also a concrete risk that IncN plasmids carrying blaCTX-M-1, which are typically conjugative and broad-host-range plasmids, are transferred from commensal E. coli to swine respiratory pathogens, thereby resulting in a veterinary therapeutic problem. On the basis of these considerations, ceftiofur and other veterinary cephalosporins should be used prudently in animal farming and prophylactic use should be avoided. More research is needed to assess the occupational health risks associated with the occurrence of CTX-M-1-producing E. coli in farm workers as well as to investigate the possible zoonotic transmission of IncN plasmids carrying blaCTX-M-1 through the food chain.
We would like to thank Tina Struve and Søren Saxmose Nielsen for help with sampling and isolation and Henrik Hasman and Kristina Kadlec for assistance with plasmid characterization.
Published ahead of print on 2 February 2009. ![]()
Supplemental material for this article may be found at http://aac.asm.org/. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»